CRISPR-Cas9: How research on a bacterial RNA-guided mechanism opened new perspectives in biotechnology and biomedicine

EMBO Molecular Medicine

Volumn 7, Issue 4, 2015, Pages 363-365

  Charpentier, Emmanuelle ^a,b,c  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UMEÅ UNIVERSITY   (Sweden)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL RNA; CAS9 PROTEIN; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CRISPR ASSOCIATED PROTEIN; MESSENGER RNA; PLASMID DNA; RIBONUCLEOPROTEIN; RNA; UNCLASSIFIED DRUG; VACCINE; VIRULENCE FACTOR; ZINC FINGER NUCLEASE;

ADAPTATION; ADAPTIVE IMMUNITY; ARCHAEON; ARTICLE; BACTERIA; BACTERIAL CELL; BACTERIAL GENOME; BACTERIAL VIRULENCE; BACTERIOPHAGE; BIOGENESIS; BIOMEDICINE; BIOTECHNOLOGY; CRISPR CAS SYSTEM; DNA SEQUENCE; GENE EXPRESSION; GENE TARGETING; HOST PATHOGEN INTERACTION; HUMAN; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; STEM CELL; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS THERMOPHILUS; ANIMAL; MEDICAL RESEARCH; PROCEDURES; TRENDS;

ANIMALS; BIOMEDICAL RESEARCH; BIOTECHNOLOGY; CRISPR-CAS SYSTEMS; HUMANS; RNA, BACTERIAL;

EID: 84926069381     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201504847     Document Type: Article

References (11)

1. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315: 1709-1712
2. Barrangou R, Marraffini LA (2014) CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity. Mol Cell 54: 234-244
3. Damian M, Porteus MH (2013) A crisper look at genome editing: RNA-guided genome modification. Mol Ther 21: 720-722
4. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471: 602-607
5. Deveau H, Barrangou R, Garneau JE, Labonté J, Fremaux C, Boyaval P, Romero DA, Horvath P, Moineau S (2008) Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 190: 1390-1400
6. Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346: 1258096
7. Garneau JE, Dupuis MÈ, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH, Moineau S (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468: 67-71
8. Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157: 1262-1278
9. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821
10. Sampson TR, Saroj SD, Llewellyn AC, Tzeng YL, Weiss DS (2013) A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497: 254-257
11. Sapranauskas R, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V (2011) The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res 39: 9275-9282